vaccines
US Booster Eligibility Decision
The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.
Booster for At-Risk
The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.
Hundreds of Millions More to Share
The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.
Two J&J Doses
Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.
Pfizer-BioNTech Vaccine Response in Kids
The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.